Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin
US9505822B2 · kind B2 · utility
0Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2014 |
| Grant date | Nov 29, 2016 |
| Priority date | — |
| Expiry date | Oct 9, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2123/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.